VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0960393
Sex: U
Age:
State: IL

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210109; Test Name: PCR COVID test; Result Unstructured Data: Test Result:unknown result; Comments: pending

Allergies:

Symptoms: I had a very mild cough; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, on 06Jan2021 at single dose for COVID-19 immunisation. Medical history included being exposed at home to a symptomatic COVID patient on 04Jan2021. Concomitant medications were not reported. Patient previously received first dose of BNT162B2 on 16Dec2020 for COVID-19 immunisation. Patient received the second COVID vaccine on 06Jan2021 and had a very mild cough from 06Jan2021 to 09Jan2021. Patient had PCR COVID test on 09Jan2021 and pending result. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960394
Sex: F
Age:
State:

Vax Date: 12/20/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: she has a low grade fever; a swollen left node on the neck; This is a spontaneous report from a Pfizer-sponsored program. A contactable nurse reported for self that a female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Dec2020 at single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. patient got her 1st dose last Dec2020 and is scheduled for the 2nd dose today. She mentioned she has a low grade fever and a swollen left node on the neck. She wants to know if that will contraindicate on taking the vaccine. Outcome of events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960395
Sex: M
Age:
State: MI

Vax Date: 01/09/2021
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: Fever; Result Unstructured Data: Test Result:low-grade fever

Allergies:

Symptoms: experiencing low-grade fever.; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored. The male patient received first dose of bnt162b2 (BNT162B2), unknown on 09Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced low-grade fever on an unspecified date. It was reported as " had the vaccine yesterday and i had like a really low-grade fever and I was wondering if it was okay to just take some Tylenol for the fever". The outcome of the event was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0960396
Sex: M
Age:
State: PA

Vax Date: 12/21/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills; fatigue; This is a spontaneous report from a contactable physician. An elderly (reported as 65+ Years) male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose on 21Dec2020 (Lot number: ej1685) via an unspecified route of administration, second dose on 11Jan2021 (Lot number: e21685) via intramuscular, both at single dose for COVID-19 immunisation. Medical history included known allergies to penicillin and erythromycin. The patient's concomitant medications were not reported. The patient experienced chills and fatigue on an unspecified date. No treatment was received for adverse events. The patient received vaccine in hospital. No other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. The outcome of events was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 0960397
Sex: U
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: felt achy and sore; clammy; This is a spontaneous report from a non-contactable nurse (patient) via Pfizer sales representative. A patient of unspecified age and gender received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Jan2021 at single dose for COVID-19 immunization. Patient was vaccinated by employer. The patient's medical history and concomitant medications were not reported. The patient received first dose of bnt162b2 on an unspecified date. The patient felt achy, clammy and sore in Jan2021. The outcome of events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0960398
Sex: M
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210109; Test Name: fever; Result Unstructured Data: Test Result:101.2

Allergies:

Symptoms: Chills/rigors; back ache; headache; temp was now 101.2; feeling really ill; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient was feeling really ill from his second vaccine shot, on 09Jan2021, he experienced chills for 12 hours, rigors, back ache, headache. First dose was only arm soreness. It was reported temp was now 101.2 (unit not provided). The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected. Information about Lot/Batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0960399
Sex: F
Age:
State: NJ

Vax Date: 01/10/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: temperature; Result Unstructured Data: Test Result:99.4 Fahrenheit; Test Date: 202101; Test Name: temperature; Result Unstructured Data: Test Result:101.2 Fahrenheit; Test Date: 202101; Test Name: pulse; Result Unstructured Data: Test Result:in the 90s; Test Date: 202101; Test Name: oxygen level; Result Unstructured Data: Test Result:97-99 %

Allergies:

Symptoms: Body aches; Heaviness in her chest; Pulse is in the 90s; Now her temperature was 101.2 degrees F; Soreness in her left arm; Chills; Not feeling too well/flu-like feeling; Not feeling too well/flu-like feeling; Slight headache / headache; This is a spontaneous report from a contactable consumer (patient). This 57-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231), via an unknown route, on 10Jan2021 at 15:00 at single dose in the left arm for COVID-19 immunisation. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EZ0140) administered in the upper left arm on 20Dec2020 (at 14:45-15:00) and developed a little headache, soreness and was tired (reported under AER 2021026236). Relevant medical history included thyroid, cholesterol and blood pressure (as reported). The patient was taking concomitant medications for underlying medical history. No other vaccine was received in four weeks. In the evening yesterday she was not feeling too well. She had a slight headache; body aches and she could get rid of the headache. She clarified that last night she felt chilly, she had the chills. By 10am this morning she did not feel well, she had a pretty bad headache and felt like she had a temperature. Her temperature earlier today was 99.4 degrees F and now her temperature was 101.2 degrees F. Her whole body feels like she was having aches, stated it is like a flu-like feeling, she had heaviness in her chest, her pulse will not go out of the 90s. She took her oxygen level and it was between 97-99%. She had also soreness in her left arm. She asked if these are common side effects, or something to be concerned about. Therapeutic measures taken as result of the events included ibuprofen (ADVIL). The outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0960400
Sex: F
Age:
State: CA

Vax Date: 01/06/2021
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: blister at the injection site that has turned into a scab; blister at the injection site that has turned into a scab; This is a spontaneous report from a contactable other health professional (nurse practitioner). This other health professional reported similar events for three patients. This is the 3rd of three reports. A 25-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284, expiry date: 30Apr2021), intramuscular at deltoid right on 06Jan2021 at 0.3 mL at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced blister at the injection site that has turned into a scab. The patient outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0960401
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 12/24/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: neurologic assessment; Result Unstructured Data: Test Result:fine; Comments: She did have a neurologic assessment, just as exam, not a testing. But, she confirms the testing was fine.

Allergies:

Symptoms: after sleeping with her neck completely craned; paresthesia in the fingers of her left hand/right paresthesia on the sole of her foot; shock-like symptoms in both hands; Fever; Malaise; This is a spontaneous report from a contactable physician (patient). A female patient of unspecified age received BNT162B2 on 22Dec2020 first dose at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. She had the first vaccination on 22Dec2020. Caller states she had a fever, malaise for 2 days afterwards (24Dec2020). Around Day 4 (26Dec2020), she developed paresthesia in the fingers of her left hand and stimulation in her left hand, there was quite a lot of involvement with her hand. She also developed right paresthesia on the sole of her foot which lasted a couple of days. She states she has never experienced the hand thing completely, for such an extensive time. She has experienced stuff before, but milder. She has never had paresthesia in 2 different places. It seems she was experiencing shock-like symptoms in both hands, that lasted about a week. She did have a neurologic assessment, just as exam, not a testing. But, she confirms the testing was fine. She experienced re-occurring paresthesia in her left hand this morning, but it was after sleeping with her neck completely craned. Caller stated she doesn't know if its vaccine related. Also, her second vaccine is due this week and she doesn't want it be worse. The outcome of event shock-like symptoms in both hands was recovered on 02Jan2021. The outcome of event paresthesia in the fingers of her left hand/right paresthesia on the sole of her foot was recovered. The outcome of other events was unknown. Information about Lot/Batch number has been requested.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported "shock-like symptoms" cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0960402
Sex: F
Age:
State: FL

Vax Date: 01/10/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Left Arm pain; This is a spontaneous report from a contactable consumer. A 90-year-old female received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1283 expired date 30Apr2021 in left arm via an unspecified route of administration on 10Jan2021 at a single dose for COVID-19 immunisation. Medical history included arthritis. Concomitant medications were not provided. On 11-JAN-2021 the patient experienced pain in her left arm. She would like to know if she can use a heating pad on it. The event outcome is not recovered and action taken is not applicable.

Other Meds:

Current Illness:

ID: 0960403
Sex: F
Age:
State: LA

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: having speech problems, it's not fluid; Sleeplessness; swelling and hurting for a couple of days after receiving Covid-19 vaccine; swelling and hurting for a couple of days after receiving Covid-19 vaccine; it might be her lithium that the Covid-19 vaccine might have interacted with; This is a spontaneous report from a contactable consumer reporting for herself. A female patient of an unspecified age received bnt162b2 (BNT162B2) vaccine , via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunisation ,and lithium (LITHIUM) , via an unspecified route of administration from an unspecified date at an unknown dose for an unspecified indication . Medical history included bipolar disorder. The patient's concomitant medications were not reported. The patient stated she was having speech problems, it's not fluid , sleeplessness , swelling and hurting for a couple of days after receiving covid-19 vaccine all the event occurred on an unspecified date with outcome of unknown . The patient suspected a possible interaction between her lithium and the Covid-19 vaccine. The patient didn't expect her psych meds coming up. Information on the Lot/Batch number has been requested.

Other Meds: Pfizer, Inc. EUA 027034;

Current Illness:

ID: 0960404
Sex: M
Age:
State: NY

Vax Date: 01/11/2021
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: covid; Result Unstructured Data: Test Result:negative; Comments: He has 3 tests after that which were all negative.; Test Name: covid; Result Unstructured Data: Test Result:negative; Comments: He has 3 tests after that which were all negative.; Test Name: covid; Result Unstructured Data: Test Result:negative; Comments: He has 3 tests after that which were all negative.; Test Date: 2020; Test Name: SARS-CoV-2 test positive; Result Unstructured Data: Test Result:positive; Comments: did catch covid sometime in Jun2020 or Jul2020 last year. He tested positive for covid at that time.; Test Name: weight; Result Unstructured Data: Test Result:lost

Allergies:

Symptoms: Drowsy; Weak; Pain in the knees/pain in his joints/joint pain from his Legs, Arms, and fingers; Both of his eyes feel tired; could not lift arm; bruised under the arm; back pain; neck pain; could not turn neck; headache; Pain with bending head down; This is a spontaneous report from a contactable consumer. A 41-year-old male consumer received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) in left arm on 11Jan2021 at 07:45 at single dose for COVID-19 immunisation at the age of 40-year-old. Medical history included HIV infection, root canal in Dec2020, COVID-19 in Jun2020 or Jul2020. Concomitant medications were unknown. Vaccination history included first dose of BNT162B2 on 21Dec2020 for COVID-19 immunisation (could not lift arm, bruised under the arm, back pain with his neck he could not turn it, he could not be on his left side where he got the shot on left arm, headache). The patient experienced drowsy, weakness, knee pain, joint pain, could not lift arm, bruised under the arm, back pain, neck pain and could not turn neck, Headache, pain with bending head down, both eyes feel tired. In Jun2020/ Jul2020, the patient resulted positive to SARS-CoV-2 test; then, the patient had 3 negative SARS-CoV-2 test; weight: lost. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960405
Sex: F
Age:
State: MA

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: Body temperature; Result Unstructured Data: Test Result:fever

Allergies:

Symptoms: Diarrhea; Fever; Chills; Muscle ache; first dose on 19Dec2020/ second dose on 08Jan2021 at 08:30; first dose on 19Dec2020/ second dose on 08Jan2021 at 08:30; Headache; fatigued; dehydration; This is a spontaneous report from a contactable consumer (patient). A 24-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: PAA156051), on 08Jan2021 at 08:30 at single dose intramuscular in right arm for COVID-19 immunisation. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK5730), on 19Dec2020 at single dose intramuscular in left arm, with no adverse effects. The second dose of BNT162B2 was administered on day 20 after first dose (unapproved schedule). The patient was taking COVID vaccine since healthcare worker (Recreational Therapist) and was vaccinated at state hospital. Patient age at time of vaccination was 24 years. No other vaccine was given within 4 weeks prior to the COVID vaccine. The patient had no relevant medical history and received no concomitant medications. The patient stated she had fever, chills, muscle aches, diarrhea, headache. She didn't report anything to her doctor. Fever started on 08Jan2021 about 12 hours after getting the second vaccine. Chills started around 7pm and headache in the night of 08Jan2021. Muscle aches started on 08Jan2021 about 8 hours after receiving the second vaccine. Diarrhea started on 09Jan2021. These symptoms lasted all day Saturday 09Jan2021, until the night. By Sunday, 10Jan2021, she was still fatigued but she was pretty much better. She reported she had recovered completely from the symptoms but she does still have a little bit of a headache, but that is probably from dehydration. Headache was resolving at the time of reporting, outcome of dehydration was unknown, other events had resolved in Jan2021.

Other Meds:

Current Illness:

ID: 0960406
Sex: U
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Soreness in the arm; Typical arm swelling; Headache; Tiredness; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) bnt162b2 (BNT162B2), via an unspecified route of administration at single dose on an unspecified date for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced soreness in the arm, typical arm swelling, headache, tiredness, all with outcome of unknown. Information on the Lot/Batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021026413 same reporter/drug/AE, different patient

Other Meds:

Current Illness:

ID: 0960407
Sex: F
Age:
State: TX

Vax Date: 01/03/2021
Onset Date: 01/03/2021
Rec V Date: 01/21/2021
Hospital: Y

Lab Data: Test Date: 20210111; Test Name: COVID-19 Rapid Test; Test Result: Positive

Allergies:

Symptoms: anterior cervical fusion; Headache; tested positive for COVID-19; tested positive for COVID-19; muscle aches; Loss of taste; Loss of smell; Nausea; sore arm; Tiredness; This is a spontaneous report from a contactable nurse (patient). A 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Lot EJ1686, intramuscular in right deltoid on 03Jan2021 11:00 at single dose for covid-19 immunisation. Medical history included ongoing essential tremor started in her 50's. The patient's concomitant medications were not reported. The patient did not receive other vaccine within four weeks. On 03Jan2021 the patient experienced sore arm and tiredness. On 07Jan2021 the patient experienced anterior cervical fusion and was hospitalized from 07Jan2021 to 09Jan2021. On 08Jan2021 the patient experienced nausea. On 09Jan2021 the patient experienced muscle aches, loss of taste and loss of smell. On unknown date the patient experienced headache. The patient was tested positive to COVID-19 on 11Jan2021. The patient did not visit Physician Office or Emergency Room. Laboratory data included COVID-19 Rapid Test positive on 11Jan2021. The outcome of the events tested positive for COVID-19, and anterior cervical fusion was unknown. The outcome of the events sore arm, tiredness, nausea, muscle aches, headache was resolving. The outcome of the events loss of taste, loss of smell was not resolved.; Sender's Comments: The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 03Jan2021, and COVID-19 test positive on 11Jan2021. No effect of the suspect vaccine could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag. Instead, the positive COVID likely represents a pre-existing infection prior to vaccine use. This 69-year-old female had medical history of ongoing essential tremor started in her 50's. The reported anterior cervical fusion was most likely due to concurrent disease, and unlikely causally related to the vaccine of BNT162B2. The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness: Essential tremor (Started in her 50's)

ID: 0960408
Sex: M
Age:
State: FL

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210112; Test Name: temp.; Result Unstructured Data: Test Result:102.6; Comments: 8-9pm, as high as 102.6 tympanic; Test Date: 20210114; Test Name: temp.; Result Unstructured Data: Test Result:101; Comments: 7 am temp is 101

Allergies:

Symptoms: Fever/as high as 102.6 tympanic/temperature was 101; This is a spontaneous report from a contactable other HCP. A 43-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: El3246), intramuscular in left arm on 12Jan2021 09:00 at a single dose for covid-19 immunization. Medical history included diabetes mellitus. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included metformin, rosuvastatin, acyclovir [aciclovir] (ACYCLOVIR), lisinopril, and fenofibrate. The patient previously received the first dose of bnt162b2 on 22Dec2020 09:00 intramuscular in left arm. The patient experienced fever that started at 8pm to 9pm on 12Jan2021. The fever reached as high as 102.6 tympanic. On 14Jan2021 at 7am, temperature was 101. The outcome of the event was not recovered. No treatment was received for the event. This was assessed as non-serious. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds: ; ; ACYCLOVIR [ACICLOVIR]; ;

Current Illness:

ID: 0960409
Sex: F
Age:
State:

Vax Date: 01/09/2021
Onset Date:
Rec V Date: 01/21/2021
Hospital: Y

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:normal; Test Name: saturation; Result Unstructured Data: Test Result: normal

Allergies:

Symptoms: flushing/ facial flushing; Hives; felt warm; short of breath/ audibly gasping for air; wheeze; throat tightening; throat got so swollen and itchy; throat got so swollen and itchy; could not swallow; This is a spontaneous report from a Pfizer-sponsored program Corporate (Pfizer) Social Media Platforms. A non-contactable consumer reported that a 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunisation. Medical history included food severe allergic reaction to influenza vaccine with eggs preservative. Concomitant medications were not reported. The patient previously took influenza vaccine and experienced severe allergic reaction to the eggs preservative. The patient received BNT162B2 vaccine and informed of prior history of severe allergic reaction to influenza vaccine with eggs preservative. She has previously received flu vaccine without egg without problem. Due to her prior history of severe allergic reaction/ anaphylaxis to another vaccine, in this case flu vaccine with eggs, it was noted to proceed with caution. She was told that the vaccination could be differed until more information became available but opted to proceed with receiving the vaccine and be observed for 30 minutes. The patient developed throat tightening approximately 20 minutes after vaccination. She received EpiPen within one minute of symptoms and was sent to the emergency room immediately in a wheel chair by Nursing staff. She was evaluated in the emergency department and was hemodynamically stable. She was given IV Benadryl and was stable throughout observation. The patient then reported that 40 minutes after injection, her throat and tongue started to feel weird and tight. The pharmacy at her work hospital gave her 25 mg Benadryl and 650mg Tylenol. At about 1 hour 45 minute after injection, her throat got so swollen and itchy to the point that she could not swallow. She went to the nearest emergency room hospital and they administered decadron and Pepcid orally, and Toradol intramuscularly. On an unspecified date, the patient also reported that 5 minutes after the vaccine administration, she developed flushing, hives, felt warm and eventually short of breath. She started to wheeze and was wheeled into the emergency room with complaint of "cannot breathe, while holding throat and thrashing with facial flushness noted." She took two Benadryl and had several epinephrine shots. She was discharged from the emergency room but later that day, she started to feel short of breath again. In the emergency department, she was audibly gasping for air, however had no wheezing, had a normal saturation and normal blood pressure. She had taken another dose of her EpiPen intramuscularly and diphenhydramine 50mg by mouth prior to coming. She was then admitted to the hospital for further observation. While on the floor, she started to feel short of breath again (about 9am on 18Dec2020), which required an "RRT." The patient received another dose of diphenhydramine IV, methylprednisolone 125mg IV and several doses of IM epinephrine and also required oxygen. She was than transferred to an ICU for further care. Outcome of the events was unknown. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0960410
Sex: F
Age:
State: MI

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: Severe Allergic response; This is a spontaneous report from a contactable nurse. A 36-year-old female nurse reported that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number unknown), intramuscular at single dose into the left arm on 08Jan2021 at 12:00 PM administered at hospital for COVID-19 immunization. The patient had received the first dose of BNT162B2 intramuscular into left arm on 21Dec2020 at 02:30 PM into left arm. Concomitant drug included Lovenox. Medical history included factor five Leiden and allergy to shellfish. On 08Jan2021 at 01:00 PM the patient experienced a severe allergic response. The patient received two shots of epi pen, round the clock IV steroids, pepcid and Benadryl and was admitted into the hospital. Duration of hospitalization reported as 6. The adverse event resulted in Emergency room/department or urgent care. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was unknown.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of anaphylactic reaction cannot be excluded, considering the plausible temporal relationship and the known adverse event profile of the suspect product. Severe allergic reaction is the known risk for the product. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: LOVENOX [ENOXAPARIN SODIUM]

Current Illness:

ID: 0960411
Sex: M
Age:
State: LA

Vax Date: 01/10/2021
Onset Date: 01/12/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Allergic reaction resulting in full body hives, swollen hands, eyelids and lips; Allergic reaction resulting in full body hives, swollen hands, eyelids and lips; Allergic reaction resulting in full body hives, swollen hands, eyelids and lips; Allergic reaction resulting in full body hives, swollen hands, eyelids and lips; Allergic reaction resulting in full body hives, swollen hands, eyelids and lips; This is a spontaneous report from a contactable other health professional (patient). A 27-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were unknown) at the age of 26 years old, via intramuscular route in the left arm, on 10Jan2021 at 13:00, at a single dose, for COVID-19 immunization. Medical history included high blood pressure. The patient's concomitant medications were not reported. The patient has no known allergies. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 12Jan2021, at 07:30 A.M., the patient experienced allergic reaction resulting in full body hives, swollen hands, eyelids and lips. The patient did not receive treatment for the events. Outcome of the events was recovering. The patient has not been tested for COVID-19 since vaccination. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960412
Sex: F
Age:
State: SC

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: broke out in rash/hives all over; broke out in rash/hives all over; mild tongue swelling; sob throat felt sore and swollen; sob throat felt sore and swollen; swelling at injection site; redness at injection site; itching at injection site; feverish; This is a spontaneous report from a contactable other healthcare professional (patient). A 33-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number=Ej1685, via an unspecified route of administration on left arm from 07Jan2021 11:00 to 07Jan2021 11:00 at SINGLE DOSE (dose 2) for COVID-19 immunisation. The patient as no known allergies, no other medical history, and no allergies to medications, food, or other products. Historical vaccine includes first dose of BNT162B2 on 18Dec2020, time=12:45 PM, vaccine location=Left arm, lot number=Eh9899. The patient's concomitant medications were not reported. On 08Jan2021 05:00 AM, the patient experienced post vaccine swelling, redness, itching at injection site and feverish. On 13Jan2021, the patient broke out in rash/hives all over with mild tongue swelling and sob throat felt sore and swollen for a short time. The patient went to physician and received steroid injection and Benadryl. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0960413
Sex: F
Age:
State:

Vax Date: 12/23/2020
Onset Date: 12/29/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20201229; Test Name: COVID-19 test swab; Test Result: Positive

Allergies:

Symptoms: COVID test/ tested positive; COVID test/ tested positive; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received first dose of bnt162b2 (Lot Number: EL1284), via an unspecified route of administration on 23Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced COVID test/ tested positive on 29Dec2020, chills, body aches on 25Dec2020. She was supposed to get the second dose of the COVID Vaccine at the time of this report. She got the first dose on 23Dec2020 and after 2 days got chills and body aches. She took a COVID test swab on 29Dec2020. Then she tested positive on 31Dec2020. She was asymptomatic besides chills and body aches. She was in Isolation for 14 days and is done. She was wondering if she could take the second dose. Caller was a nursing assistant. The patient underwent lab tests and procedures which included COVID test swab: positive on 29Dec2020. The outcome of events was unknown.; Sender's Comments: The association between the event lack of effect (COVID test swab positive) with BNT162b2 can not be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0960414
Sex: F
Age:
State: PA

Vax Date: 01/11/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210112; Test Name: Body temperature; Result Unstructured Data: Test Result:fever Fahrenheit; Test Date: 20210113; Test Name: Body temperature; Result Unstructured Data: Test Result:was fine during the day Fahrenheit; Test Date: 20210113; Test Name: Body temperature; Result Unstructured Data: Test Result:past 100 degree F Fahrenheit; Comments: at night

Allergies:

Symptoms: diarrhea; nausea; she was sick with a high fever; chills; felt deathly sick; couldn't get out of bed all day; headache; a little bit of a sore throat; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, lot # and expiration not available) intramuscular in left arm at single dose on 11Jan2021 09:30 for Covid-19 immunisation, for precaution because she worked in hospital, administered ad hospital. There was no prescriber. Medical history included asthma diagnosed 30 years before when she was in her 20's around 1990, hypothyroidism. Family medical history was none. Concomitant medication included only levothyroxine sodium (SYNTHROID) taking for 30 years for hypothyroidism. The patient received the 1st dose of bnt162b2 (BNT162B2, lot # and expiration not available) intramuscularly in left arm on 21Dec2020 09:30 (within 4 weeks prior to the 2nd dose of BNT162B2 suspect) Covid-19 immunisation and she was fine. No adverse events occurred following prior vaccinations. No additional vaccines administered on same date of BNT162B2 suspect. On 12Jan2021, she was felt deathly sick at 15:00. On 11Jan2021 she experienced headache at 17:00. On 12Jan2021, at 17:00 she experienced high fever and chills and couldn't get out of bed all day. On 13Jan2021, she was fine during the day. On 13Jan2021 night, she had a fever that went past 100 degree F, she experienced diarrhea and nausea 02:00. The fever came and went. In Jan2021 she had a little bit of a sore throat. The patient underwent lab tests and procedures which included body temperature: a fever on 12Jan2021; wsa fien on 13-JAN-2021, fever went past 100 degree F, on 13Jan2021at night. No other relevant test performed. She has been out of work since 12Jan2021. On 14Jan2021 she still has diarrhea and nausea with a little bit of a sore throat as well. No ER or physician's office was required. The outcome of felt deathly sick and chills was recovering, of headache, high fever, diarrhea and nausea was not recovered, of couldn't get out of bed all day and a little bit of a sore throat was unknown. She was not sure if her new symptoms meant she should get COVID testing and would like to find out. Information on lot number/batch number was requested.

Other Meds: SYNTHROID

Current Illness:

ID: 0960415
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: up most of the night; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization, and methylprednisolone (MEDROL), via an unspecified route of administration from an unspecified date at unknown dose for an unspecified indication. The patient's medical history and concomitant medications were not reported. The patient took a Medrol dosepak and she was up most of the night with 4 pillows. The action taken in response to the event for methylprednisolone and event outcome were unknown. Information on the lot/batch number has been requested.

Other Meds: Medrol

Current Illness:

ID: 0960416
Sex: U
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: mild soreness in arm; This is a spontaneous report from a contactable physician received via a Pfizer sales representative. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in arm on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced mild soreness in arm on an unspecified date. The patient outcome of the event was unknown. The information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 0960417
Sex: F
Age:
State:

Vax Date:
Onset Date: 01/13/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever; This is a spontaneous report from a non-contactable consumer. A 37-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: unknown), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fever on 13Jan2021 with outcome of recovered. No treatment received for the adverse event. The patient did not diagnosed with COVID-19 prior to vaccination, and did not tested for COVID-19 since the vaccination. The case is non serious. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0960418
Sex: F
Age:
State:

Vax Date: 12/21/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: mammo screen; Result Unstructured Data: Test Result:Swollen lymph node discovered; Test Date: 20210111; Test Name: Ultrasound; Result Unstructured Data: Test Result:unknown result; Comments: follow-up

Allergies:

Symptoms: Swollen lymph node; This is a spontaneous report from a contactable physician (patient). A 43-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), the first dose on 21Dec2020 and the second dose on 11Jan2021 both via an unspecified route of administration at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced swollen lymph node on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included mammo screen: swollen lymph node on unknown date and ultrasound scan on 11Jan2021 with unknown results as follow-up. A new follow-up was scheduled in 6 weeks. Radiologist suspected side effect from BNT162b2 shots received 21Dec2020 and 11Jan2021. Information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960419
Sex: F
Age:
State: OK

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/21/2021
Hospital: Y

Lab Data: Test Date: 20210101; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Shortness of breath; Headache; Tinnitus; This is a spontaneous report from a contactable Physician. A 55-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 31Dec2020 at single dose for covid-19 immunisation. Medical history included type 2 diabetes mellitus, hypertension, gastroesophageal reflux disease and asthma, all from an unknown date and unknown if ongoing. Known allergies reported: drug intolerances with nausea/vomiting to Opiates, TRULICITY, sulfa antibiotics. The patient's concomitant medications were not reported. The vaccine was administered at Hospital Facility. It was unknown If other vaccine were administered in four weeks. The patient did not experience COVID prior vaccination. The patient was tested for COVID post vaccination on 01Jan2021 and was negative. On 31Dec2020 within minutes of vaccination the patient experienced shortness of breath, headache and tinnitus. The events required visit to Physician Office and Emergency Room. The patient was admitted to hospital for 7 days. Therapeutic measures taken as a result of the events included epinephrine without benefit, prednisone course but tinnitus remained about 12 days since vaccination, corticosteroids, and H1 and H2 antagonists. The patient underwent lab tests and procedures which included COVID test post vaccination (Nasal Swab) on 01Jan2021 with negative result. The outcome of the events was recovered with sequelae. Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the events dyspnea, headache and tinnitus cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0960420
Sex: F
Age:
State: CA

Vax Date: 12/18/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210104; Test Name: Nasal swab for Coronavirus Pandemic 2019-NCOV (NAA); Test Result: Negative

Allergies:

Symptoms: Flu-like symptoms; Bilateral cheek numbness; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: El0140), intramuscular in right arm, on 18Dec2020 at 14:30, at a single dose, for COVID-19 immunization. The patient's medical history included was not reported. The patient's concomitant medication included ascorbic acid (VITAMIN C). The patient previously took benzoyl peroxide and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The most recent COVID-19 vaccine was administered in a hospital facility. On an unspecified date after the first dose, the patient experienced flu-like symptoms for 48 hours plus bilateral cheek numbness for two weeks. The events were considered non-serious. No treatment was received for the adverse events. The patient underwent laboratory tests and procedures which included nasal swab for Coronavirus Pandemic 2019-NCOV (NAA) that was negative on 04Jan2021. The patient recovered from the events on an unspecified date.

Other Meds: VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 0960421
Sex: M
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: HA; slight fever; This is a spontaneous report from a contactable consumer. This consumer reported similar events for two patients. This is 2nd of two reports. A male patient (reporter's Grandson) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch Number and Expiration Date unknown) via an unspecified route of administration on an unknow date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications was not reported. On an unspecified date the patient Headache (HA) and slight fever. The outcome of events was unknown. Information on the batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021024982 Same reporter/drug/event, different patient.

Other Meds:

Current Illness:

ID: 0960422
Sex: F
Age:
State: MI

Vax Date: 12/20/2020
Onset Date: 12/20/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: emesis; upset stomach; Sweating; headache; This is a spontaneous report from a contactable other healthcare professional. A 54-year-old female patient received the first dose of bnt162b2 (COVID-19 vaccine, brand: Pfizer) lot no: EK5730, intramuscular in left arm on 20Dec2020 09:30 at a single dose for Covid-19 immunization in a hospital. Medical history included allergies pineapple and coconut. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. Concomitant medication included warfarin sodium (JANTOVEN), sertraline, and metformin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took cefaclor (CECLOR) and zithromax (Z-PACK) and experienced allergies to both. On 20Dec2020, after the first shot, the patient experienced emesis within 40 minutes. Then on unspecified dates, the patient experienced upset stomach for 3 hours approximately, sweating and headache lasting about 4 hours. Treatment was not given for the events. The patient recovered from the events.

Other Meds: JANTOVEN; ;

Current Illness:

ID: 0960424
Sex: F
Age:
State: MO

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: fever; Result Unstructured Data: Test Result:100.4

Allergies:

Symptoms: Fever; In morning my temperature was 100.4; Headache; Felt tired from weak; Felt tired from weak; Feels bad; Chills/shivering; This is a spontaneous report from a contactable nurse (patient). A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL3248), via an unspecified route of administration in the left arm on 09Jan2021 as single dose for COVID-19 immunization. Medical history included covid-19 in Oct2020. The patient's concomitant medications were not reported. The patient experienced fever; in morning my temperature was 100.4 on 10Jan2021 with outcome of unknown; headache on 10Jan2021 with outcome of unknown; felt tired from weak in Jan2021 with outcome of unknown; chills/shivering in Jan2021 with outcome of recovered in Jan2021, feels bad in Jan2021 with outcome of unknown. The patient underwent lab tests and procedures which included fever at 100.4 in Jan2021. Details were as follows: patient received the first dose of the Covid-19 vaccination and woke up with a fever and a bad headache in the morning. As it related to casualty, the reporting nurse indicated yes and commented that she was fine the day prior and then when she woke up this morning, she had fever and a bad headache. She indicated that she felt like a little; she got it in the morning around the 11 O'clock. And then by the evening she felt tired. She thought that she was just tired from the week. And when she woke up on this morning, or in middle of the nigh, she was shivering a little bit. She fell asleep and woke up the next morning, with a temperature of 100.4. She said that she did not feel really that bad; she had a headache; she did not have shivering or chills then. Therapeutic measures were taken as a result of fever; in morning my temperature was 100.4, headache, felt tired from weak, shivering, feels bad, chills and felt tired from weak ; she took ibuprofen. The chills/shivering recovered in Jan2021; the outcome of the other events was not reported

Other Meds:

Current Illness:

Date Died:

ID: 0960426
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: expired before receiving the second dose; This is a spontaneous report from a contactable nurse. This nurse reported similar death events for 8 patients. This report is for 1st of 8 patient. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. The patient medical history was and concomitant medications were not reported. The patient expired before receiving the second dose on an unspecified date. It was not reported if an autopsy was performed. Information about Lot/Batch number is requested.; Sender's Comments: Current information is very limited for full assessment. The patient died following the vaccine use; further information such as patient demographics, complete medical history, concomitant medications, concurrent illness and event term details especially death cause and autopsy results are needed for meaningful evaluation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021034597 same drug, reporter and event but different patient;US-PFIZER INC-2021034598 same drug, reporter and event but different patient;US-PFIZER INC-2021034599 same drug, reporter and event but different patient;US-PFIZER INC-2021034600 same drug, reporter and event but different patient;US-PFIZER INC-2021034601 same drug, reporter and event but different patient;US-PFIZER INC-2021034603 same drug, reporter and event but different patient;US-PFIZER INC-2021034596 same drug, reporter and event but different patient.; Reported Cause(s) of Death: expired before receiving the second dose

Other Meds:

Current Illness:

Date Died:

ID: 0960427
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: expired before receiving the second dose; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 8 patients. This report is for 2nd of 8 patients. A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient expired before receiving the second dose on an unspecified date. It was not reported if an autopsy was performed. Information about Lot/Batch number is requested.; Sender's Comments: Current information is very limited for full assessment. The patient died following the vaccine use; further information such as patient demographics, complete medical history, concomitant medications, concurrent illness and event term details especially death cause and autopsy results are needed for meaningful evaluation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: expired before receiving the second dose

Other Meds:

Current Illness:

Date Died:

ID: 0960428
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: expired before receiving the second dose; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 8 patients. This report is for 3rd of 8 patients. A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient expired before receiving the second dose on an unspecified date. It was not reported if an autopsy was performed. Information about Lot/Batch number is requested.; Sender's Comments: Based on the reasonable temporal association, the Company cannot completely exclude the possible causality between the reported death and the administration of COVID 19 vaccine, bnt162b2. However, more information on the patient's underlying medical condition, concomitant medications, patient's age group, clinical course and relevant lab tests would be helpful for the Company to make a more meaningful causality assessment. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.; Reported Cause(s) of Death: expired before receiving the second dose

Other Meds:

Current Illness:

Date Died:

ID: 0960429
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: expired before receiving the second dose; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 8 patients. This report is for 4th of 8 patient. A patient of unspecified age and gender received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient expired before receiving the second dose on an unspecified date. The patient died on an unspecified date. It was not reported if an autopsy was performed. Information about Lot/Batch number has been requested.; Sender's Comments: Current information is very limited for full assessment. The patient died following the vaccine use; further information such as patient demographics, complete medical history, concomitant medications, concurrent illness and event term details especially death cause and autopsy results are needed for meaningful evaluation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021034595 same drug, reporter and event but different patient; Reported Cause(s) of Death: expired before receiving the second dose

Other Meds:

Current Illness:

Date Died:

ID: 0960430
Sex: U
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 7 residents expired before receiving the second dose; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 8 patients. This report is for 6th of 8 patients. A patient of unspecified age and gender received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient expired before receiving the second dose on an unspecified date. It was not reported if an autopsy was performed. Information on the lot/batch number has been requested.; Sender's Comments: The event death is assessed as related to BNT162b2 vaccine and documented as such in the global safety database until sufficient information is available to allow an unrelated causality assessment. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021034595 same drug, reporter and event but different patient; Reported Cause(s) of Death: 7 residents expired before receiving the second dose

Other Meds:

Current Illness:

Date Died:

ID: 0960431
Sex: U
Age:
State: OH

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: expired before receiving the second dose; This is a spontaneous report from a contactable nurse. This nurse reported similar death events for 8 patients. This report is for 7th of 8 patient. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. The patient medical history was and concomitant medications were not reported. The patient expired before receiving the second dose on an unspecified date. It was not reported if an autopsy was performed. Information about Lot/Batch number is requested.; Sender's Comments: Current information is very limited for full assessment. The patient died following the vaccine use; further information such as patient demographics, complete medical history, concomitant medications, concurrent illness and event term details especially death cause and autopsy results are needed for meaningful evaluation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021034595 same drug, reporter and event but different patient; Reported Cause(s) of Death: expired before receiving the second dose

Other Meds:

Current Illness:

ID: 0960433
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: After getting the second dose, three days later every time she takes progesterone she experiences shortness of breath; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization, and progesterone, via an unspecified route of administration from an unspecified date at an unspecified dose for an unspecified indication. The patient's medical history and concomitant medications were not reported. The patient had her first covid vaccine (BNT162B2) last 18Dec2020 and had no reaction to the first dose. After getting the second dose, three days later every time she takes progesterone she experiences shortness of breath from an unspecified date. The patient was asking what she can do about it and also asked if the vaccine can wear off even though the immunity from the covid vaccine won't take effect as she needs to take her progesterone (as reported). The action taken in response to the event for progesterone was unknown. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds: Progesterone

Current Illness:

ID: 0960434
Sex: F
Age:
State: LA

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nose bleed; Dizziness; it left me little weak; This is a spontaneous report from a contactable consumer. This 75-year-old female consumer (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0142) at single dose for COVID-19 immunization on 09Jan2021. Relevant history included High blood pressure. Relevant concomitant drugs included Losartan for Blood pressure high, and hydrochlorothiazide. The patient had the first Covid 19 Vaccine on 09Jan2021 and she knew little bit dizziness was normal but she had a nose bleed in the next morning that she could hardly stop, she finally got it stopped it, it left she little weak so she just wanted to report that, she did not know if anyone had ever had that before (Hence, MI was made). Outcome of event Nose bleed was recovered, the outcome of other event was unknown.

Other Meds: ;

Current Illness:

ID: 0960435
Sex: F
Age:
State: TX

Vax Date: 12/18/2020
Onset Date: 12/30/2020
Rec V Date: 01/21/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: Internal brain bleeding 10 days after 1st dose covid vaccine; Brain damage; confused; suffering memory loss; This is a spontaneous report from a contactable Physician (patient). This 39-year-old female patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular on 18Dec2020 14:30 at single dose (lot number: EJ1685) for covid-19 immunisation. Medical history and concomitant medications were unknown. The patient experienced internal brain bleeding and brain damage on 30Dec2020 07:30 after 1st dose covid vaccine. Brain surgery received on 29Dec2020. Events were still recovering. Patient was confused and suffering memory loss on 30Dec2020 07:30. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event), disability or permanent damage. Days for hospitalization was 16. The patient received treatment for events as brain surgery due to internal brain bleeding. The patient was not pregnant. The patient had no COVID prior vaccination, no COVID tested post vaccination. Outcome of the events was recovering.; Sender's Comments: The reported internal brain bleeding and brain damage with confused and memory loss more likely represented intercurrent disease, and less likely causally related to 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE). The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0960436
Sex: M
Age:
State: NM

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: The patient had Hemolytic Anemia with symptoms starting within the first 24 hours of vaccine administration.; The first dose received on 18Dec2020 and the second dose received on 06Jan2021; The first dose received on 18Dec2020 and the second dose received on 06Jan2021; This is a spontaneous report from a contactable consumer. This consumer reported for a 37-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose for COVID-19 immunization on 06Jan2021. Relevant history and concomitant drugs were unknown. The patient previously received the first dose of BNT162B2 on 18Dec2020 for COVID-19 immunization. The patient did not receive other vaccine in four weeks of vaccination. No known allergies. The patient had Hemolytic Anemia with symptoms starting within the first 24 hours of vaccine administration on 06Jan2021. The patient had emergency room visit and physician office visit. No treatment was received (as reported). Outcome of event was unknown. The event was assessed as serious with serious criteria: Life-threatening, disability. Information about Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 0960438
Sex: M
Age:
State: OH

Vax Date: 01/14/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210116; Test Name: Nasal Swab; Test Result: Negative ; Comments: COVID test name post vaccination=Roche Cobas

Allergies:

Symptoms: Patient suffered cardiac arrest, though most likely result of illicit substance use; patient had been feeling unwell with nausea and GI discomfort after receiving the vaccine 36 hours prior to; patient had been feeling unwell with nausea and GI discomfort after receiving the vaccine 36 hours prior to; patient had been feeling unwell with nausea and GI discomfort after receiving the vaccine 36 hours prior to; Patient suffered cardiac arrest, though most likely result of illicit substance use; This is a spontaneous report from a contactable physician. A 33-years-old male patient received bnt162b2 (BNT162B2, lot unknown), intramuscular on 14Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient suffered cardiac arrest 17Jan2021 11:15, though most likely result of illicit substance use since Jan2021, though patient had been feeling unwell with nausea and GI discomfort on 15Jan2021 23:15 after receiving the vaccine 36 hours prior to his arrest. The events were serious due to Life threatening illness (immediate risk of death from the event) and Disability or permanent damage. The patient had no COVID prior vaccination. COVID test type post vaccination=Nasal Swab on16Jan2021, test result was Negative. COVID test name post vaccination=Roche Cobas. The event outcome was not recovered. No treatment was received to events. No follow-up attempts are possible; information on lot/batch number cannot be obtained.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the events cardiac arrest, substance abuse, abdominal discomfort, malaise and nausea cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0960439
Sex: F
Age:
State: MI

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Cardiac event; Paralysis; Fever; Numbness; Chest Pains; Dizziness; Weakness; This is a spontaneous report from a contactable consumer (patient). A 30-years-old female patient started to receive first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Left arm on 15Jan2021 14:15 at SINGLE DOSE for covid-19 immunisation. The patient was not pregnant. Medical history included tachycardia, Pre-ventricular contractions, allergies to Latex, covid-19 (reported as covid prior vaccination: Yes). Concomitant medication included metoprolol and multivitamin. No other vaccine received in four weeks. On 15Jan2021 14:30, the patient experienced chest pains, dizziness, weakness. On 15Jan2021 18:20, the patient experienced cardiac event, paralysis, fever, numbness, chest pains. The events resulted in: [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Life threatening illness (immediate risk of death from the event)]. Treatment received for the events. No covid tested post vaccination. The outcome of the events was recovering. Information on batch/lot number was requested.

Other Meds:

Current Illness:

ID: 0960440
Sex: F
Age:
State: WA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nauseous; Fever; Chills; Headache; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL1283), via an unspecified route of administration on 08Jan2021 at single dose for covid-19 immunization. Medical history was none. The patient's concomitant medications were not reported. The patient supposed to be calling after she get vaccine to report any side effects. The patient just nauseous, fever, chills, headache. The patient had started symptoms on 09Jan2021 and still had her symptoms today (10Jan2021). The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0960441
Sex: M
Age:
State: NY

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: blood work; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210109; Test Name: temperature; Result Unstructured Data: Test Result:very slight fever 99.2

Allergies:

Symptoms: Chills/shivering; Very slight fever 99.2; Felt a little achy; due date for the next shot: 26Jan2021; This is a spontaneous report from a contactable consumer. This 73-year-old male consumer (patient) reported that he received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route on 08Jan2021 at single dose for COVID-19 immunization. Medical history included blood pressure, cholesterol and acid reflux. Concomitant drugs included hydrochlorothiazide for blood pressure, pravastatin sodium (PRAVACHOL) for cholesterol, omeprazole for acid reflux and famotidine (PEPCID) for acid reflux. Patient stated he had chills, shivering, a very slight fever 99.2, and felt a little achy yesterday afternoon (09Jan2021) with outcome of recovered in Jan2021. Patient had blood work with unknown results. Patient took a couple of paracetamol (TYLENOL) as treatment. Patient stated he was told that the side effects would be within 24 hours but this was 2 days later (not confirmed appropriately). It was reported the due date for the next shot: 26Jan2021. Information on the lot/batch number has been requested.

Other Meds: ; PRAVACHOL; ; PEPCID [FAMOTIDINE]

Current Illness:

ID: 0960442
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Allergic reaction; This is a spontaneous report from a non contactable consumer reporting for self. A patient of unspecified age and gender received bnt162b2 (BNT162B2) vaccine , via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunisation . The patient medical history and concomitant medications were not reported. The patient experienced allergic reaction on an unspecified date with outcome of unknown. No follow-up attempts are possible. No further information is expected. Information about Lot/Batch Number cannot be obtained.

Other Meds:

Current Illness:

ID: 0960443
Sex: F
Age:
State: SC

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I brushed my teeth and then all of a sudden my throat closed up and I couldn't breathe/when my throat get bad; I brushed my teeth and then all of a sudden my throat closed up and I couldn't breathe; I started hyperventilating because I was scared; I started hyperventilating because I was scared; I felt strange but not sick or anything like that, it hit me like with a ton of bricks; I was shaking so bad I couldn't even hold anything; I was aching all the way from head to toe; I got my first Pfizer BioNTech COVID 19 Vaccine on 22Dec/And then I had my second one on 08Jan; I have residual like I am sill aching in my back; I tasted the food, it tasted funny, like not the same but then at the end of the day I could taste food like normally; I had sort of a cough but not like I urge to cough but it was not like chronic; Muscle soreness; still tired; This is a spontaneous report from a contactable consumer reported for herself. A 58-years-old female patient received the second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246), via an unspecified route of administration on right deltoid on 08Jan2021 08:30 at single dose for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient previously took the first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on left deltoid on 22Dec2020 at single dose for covid-19 immunisation. The patient stated she got her first Pfizer BioNTech COVID 19 Vaccine on 22Dec2020 and had no issues really with that one. And then she had second one on 08Jan2021. The first she got in her left deltoid and the second one she had on 08Jan2021, she had in her right deltoid. It's towards 8:30 in the morning roughly is when she had it. So, during the day went on 08Jan2021, she felt strange but not sick or anything like that. And the day went on to eat something and then came home. And then she'd say at around 7:30 it hit her like with a ton of bricks. She was shaking so bad, she couldn't even hold anything. And then she was aching all the way from head to toe. And she was like she will get her tooth brush at least. So, she brushed her teeth and then all of a sudden her throat closed up on 08Jan2021 around 7:30 pm and she couldn't breathe. And she stated she was like "oh my gosh and then it sort of opened up enough for me to scream for my husband, I yell for him to come and then it did it again, it closed up again. And when he came, I started hyperventilating because I was scared. And he calmed me down and rub my back and everything, and it went away. But it scared me. But the shaking lasted probably all through night maybe till 3 in the morning because I tried not to take anything and I probably took 2 Advil. And now I have residual like I am sill aching in my back. And it's weird, in morning I tasted the food, it tasted funny, like not the same but then at the end of the day I could taste food like normally. And then I had sort of a cough but not like I urge to cough but it was not like chronic. Not a lot but it's there like if you urge to cough, it doesn't happen a lot. " The patient stated "It started on 08Jan2021 around 7:30 pm, when my throat get bad. I have muscle soreness specially in my back and I don't know in the taste in the morning the food doesn't taste right but then like it's fine towards the afternoon. And I am still tired and a slight like cough. But the cough isn't really anything, if I get urge to cough. It's not all day, it's not chronic at all." The patient started to took Advil as a treatment and stated "Well I started to because it was like 3:30 in the morning, or 2 or 3 in the morning I did take 2 Advil. And they helped with that pain." The outcome of the event taste abnormality was recovered, outcome of the other events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0960444
Sex: M
Age:
State: FL

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: allergic reaction; entire forearm turn red; allergic reaction; entire forearm turn red; This is a spontaneous report from a contactable consumer(patient). The 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL2346), Intramuscular (shot in the arm) on 07Jan2021 at single dose for covid-19 immunisation. The patient medical history included AFib(Atrial fibrillation) and Blood pressure (abnormal), problem with Afib that's pretty under control, blood pressure that's also under control (further not clarified). Concomitant medication included apixaban (ELIQUIS) and couple of different blood pressure medications. The patient experienced allergic reaction; entire forearm turned red on 07Jan2021 about 2 hours afterwards vaccination, hydrocortisone as treatment for it, topical rubbed, for about an 1 hour up to. Patient stated that he was not experiencing it and it was the short term thing he had allergic reaction. Outcome of events was recovered in Jan2021.

Other Meds: ELIQUIS

Current Illness:

ID: 0960445
Sex: U
Age:
State:

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: allergic reaction; Side effects in arm; hurts very badly; Can barely lift my arm; Nausea; really sick like bedridden for 2 days; it's continuing to increase in size and it is red and swollen and hard now; it's continuing to increase in size and it is red and swollen and hard now; it's continuing to increase in size and it is red and swollen and hard now; it's huge and it's purple; This is a spontaneous report from a contactable Other HCP (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0142) , via an unspecified route of administration on 10Jan2021 10:30 to at single dose at arm for covid-19 immunisation . Medical history included spot on arm. The patient's concomitant medications were not reported. The patient experienced side effects in my arm and it hurts very badly on 10Jan2021. The patient can barely lift arm. The patient got vaccinated 10Jan2021 around 10:30 and it came up on around 3:30 or 4 o' clock this afternoon. The patient got nauseated but no fever. The Vaccine made patient really sick like bedridden for 2 days. But the spot on arm where patient got the vaccine, it was probably 4 days ago that patient got it and it's continuing to increase in size and it is red and swollen and hard now. The patient reported that this is not like a normal injection site reaction, it's huge and it's purple and red and it feels like bee sting, it feels like an allergic reaction. The outcome of events was unknown.

Other Meds:

Current Illness:

ID: 0960446
Sex: U
Age:
State:

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: it hurt a little, not much; This is a spontaneous report from a contactable consumer (patient). A patient of unknown age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route on 10Jan2021 at single dose for COVID-19 immunization. Concomitant medications and past drug/medical history were not reported. Patient was wondering how long to keep this band aid on this. Patient had done (receiving the Covid-19 vaccine at the hospital) earlier today (10Jan2021) and it was fine and now patient was trying to exercise because it was a problem, it hurt a little, not much on 10Jan2021. Outcome of event was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm